Artisan Value Fund Q1 2026 Performance & Humana's Challenges
Artisan Partners, an investment management firm, shared its Artisan Value Fund performance results for the first quarter of 2026. The fund's Investor Class (ARTLX), Advisor Class (APDLX), and Institutional Class (APHLX) returned -3.54%, -3.50%, and -3.50%, respectively. This underperformance contrasted with the 2.10% gain for the Russell 1000® Value Index, primarily due to the market's preference for momentum-driven stocks over quality stocks, compounded by company-specific challenges.
In a volatile U.S. equity market environment, mixed outcomes characterized large-cap indices' declines against the modest growth of mid- and small-cap stocks. Volatility increased amid ongoing concerns about artificial intelligence-driven prior authorization delays, private credit impacts, and geopolitical tensions following conflicts in Iran. Despite these uncertainties, Artisan Value Fund aims to identify companies that can accrue value during various economic cycles, especially when market instabilities present advantageous investment opportunities.
One company highlighted in the fund's communication is Humana Inc. (NYSE:HUM), a major American health insurance provider. On May 22, 2026, Humana's shares closed at $307.95, reflecting a one-month return of 37.71% and a 52-week gain of 36.91%. At this time, Humana's market capitalization was $36.97 billion.
Artisan Value Fund pointed to significant declines in several portfolio stocks, including Humana, primarily due to sector-wide pressures. Managed care stocks, such as Humana, encountered challenges following a preliminary announcement from the Centers for Medicare & Medicaid Services (CMS) regarding a proposed 2027 Medicare Advantage rate increase of just 0.09%, falling short of the anticipated 4% to 6% increase. This development introduced volatility and cast doubt on Humana's multiyear improvement strategy. Additionally, the managed care sector faces rising medical costs driven by increased service utilization, with Humana experiencing difficulties in maintaining its Medicare Stars program ratings, potentially reducing future bonus payments.
Due to these challenges and Humana's significant reliance on Medicare Advantage, the Artisan Value Fund decided to exit its investment, citing potential delays in margin and earnings recovery stemming from regulatory compliance requirements and operational hurdles.
At the close of the fourth quarter, 53 hedge fund portfolios reported holding Humana, down from the previous quarter's 60. Although Humana is recognized for its investment potential, some investors believe AI stocks offer greater upside potential with reduced risk. For those interested in underpriced AI stocks, detailed reports on these opportunities are available.
For additional insights, Eagle Capital Management's perspectives on Humana and other hedge fund evaluations for the first quarter of 2026 can be found through various investor letters, providing a comprehensive overview of current market dynamics.